$RKLB

Keybanc maintains Overweight rating on Rocket Lab, $100 price target

Keybanc kept its Overweight rating on Rocket Lab with a $100 price target, suggesting a 69% upside from the Oct 14 close. The firm cites Rocket Lab's strong market position and long-term growth potential in the space sector, despite a Neutron rocket delay.

Original reporting
Published Oct 15, 2026, 12:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 12:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keybanc maintains Overweight rating on Rocket Lab, $100 price target — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

The upgrade signals confidence in long‑term growth despite short‑term setbacks.

02

Market read

Analyst rating change provides a fresh catalyst for RKLB traders.

03

What to watch

Potential funding constraints or competition from larger launch providers.

Relevance 7/10Novelty 7/10Timing: today

Background

Keybanc's note highlights Rocket Lab's market position and a temporary launch schedule delay.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Keybanc upgraded Rocket Lab to Overweight and set a new $100 price target, implying a 69% upside.

Expected impact

upward pressure as investors price in the new target

Evidence & confidence

The rating change and sizable upside potential provide a clear catalyst for short‑term buying.

Market effects

May lift sentiment for the broader small‑cap space launch sector.

Limited to U.S. investors focused on aerospace equities.

Minor, confined to niche space‑industry participants.

Counterpoint

The Neutron launch delay could temper upside, making the target optimistic.

Key entities

  • Rocket Lab

    U.S. listed aerospace launch services provider.

  • Keybanc

    Research firm issuing the Overweight rating.

Related articles

$RKLBMedAI 8/10

Rocket Lab stock tumbles as effort to take market share from SpaceX slips to 2027

Rocket Lab (RKLB) shares fell over 10% after the company delayed the first launch of its Neutron rocket to 2027, citing manufacturing issues. CEO Peter Beck attributed the delay to ensuring system margins. Neutron is key to Rocket Lab's competition with SpaceX (SPCX) in the medium-lift rocket market. The stock has dropped around 25% this year and 65% from its 52-week high. Cantor Fitzgerald maintained an Overweight rating and $122 price target.

$RKLBMed

Rocket Lab (RKLB) Delays Neutron Launch to 2027, Raising Executi

Rocket Lab (RKLB) delayed its Neutron rocket's first launch to 2027 from Q4 2026 due to manufacturing issues. The delay stems from problems with the rocket's propellant tank, requiring further testing and modifications. Neutron is key to Rocket Lab's strategy for larger missions and reusability, but repeated delays raise concerns about execution and growth timelines.

$RKLBMed

Rocket Lab Delays First Launch of New Rocket

Rocket Lab delayed the first launch of its Neutron rocket to 2027 due to carbon composite manufacturing issues, according to CEO Peter Beck. The company's shares fell 11% following the announcement and were down 9% to $53.86, giving it a market cap of $32 billion.

$RKLBMedAI 8/10

Rocket Lab Delays Neutron Rocket Launch to 2027, Stock Plummets

Rocket Lab Corp (RKLB) delayed its Neutron rocket launch to 2027 due to manufacturing issues, causing its stock to drop 14%. The company's P/S ratio is 18.9x, higher than historical levels, and insiders sold $26.96M in shares recently. RKLB has a GF Score of 77/100, with strong growth but weak profitability. The delay raises concerns about its operational efficiency and future growth prospects.

$RKLBMed

Why Rocket Lab (RKLB) Shares Are Sliding Today

Rocket Lab (RKLB) shares fell 9.8% after announcing a delay in the Neutron launch vehicle's inaugural launch to 2027 due to development and manufacturing issues. The Neutron rocket is key for expanding beyond small-satellite operations. The stock has seen significant volatility, down 29.9% year-to-date and 64.6% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Sinks After New Neutron Launch Delay

Rocket Lab's shares dropped 12% after delaying Neutron rocket's first flight to 2027 due to manufacturing issues. The company discovered air pockets in a component and is building a replacement. Testing and assembly are expected to finish in Q1 2027. Management cited strong customer demand and potential new contracts.